Researchers Submit Patent Application, "Methods And Compositions For Predicting And/Or Monitoring Diabetes And Treatments Therefor", for Approval (USPTO 20230313302).

"In still another aspect, systems for determining methylation status of at least one CpG dinucleotide and a genotype of at least one single-nucleotide polymorphism (SNP) are provided. "In some embodiments, the methods described herein further include at least a third nucleic acid primer at least 8 nucleotides in length that is complementary to a nucleic acid sequence upstream of the CpG dinucleotide. In some embodiments, the kits described herein further include at least a third nucleic acid primer at least 8 nucleotides in length that is complementary to a nucleic acid sequence downstream of the CpG dinucleotide. [Extracted from the article]